SCPHARMACEUTICALS INC. Long-Term Debt
SCPHARMACEUTICALS INC. had Long-Term Debt of $51.20 million as of 2025-06-30, per its 10-Q filed 2025-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermDebtNoncurrent · last filed 2025-08-07
- 2025-06-30: Long-term Debt, Excluding Current Maturities $51.20M.
- 2025-03-31: Long-term Debt, Excluding Current Maturities $51.05M.
- 2024-12-31: Long-term Debt, Excluding Current Maturities $51.35M.
- 2024-09-30: Long-term Debt, Excluding Current Maturities $51.10M.
| Period end | Long-term Debt, Excluding Current Maturities |
|---|---|
| 2025-06-30 | $51.20M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $51.05M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $51.35M 10-Q · filed 2025-08-07 |
| 2024-09-30 | $51.10M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $39.99M 10-Q · filed 2024-08-14 |
| 2024-03-31 | $39.38M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $38.81M 10-K · filed 2025-03-19 |
| 2023-09-30 | $38.26M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $37.74M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $37.25M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $36.79M 10-K · filed 2024-03-13 |
| 2022-06-30 | $2.46M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $4.91M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $7.35M 10-K · filed 2023-03-22 |
| 2021-09-30 | $9.78M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $12.16M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $14.52M 10-Q · filed 2021-05-12 |
| 2020-12-31 | $16.86M 10-K · filed 2022-03-22 |
| 2020-09-30 | $19.17M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $19.08M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $19.00M 10-Q · filed 2020-05-12 |
| 2019-12-31 | $18.91M 10-K · filed 2021-03-23 |
| 2019-09-30 | $18.84M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $5.09M 10-Q · filed 2019-08-07 |
| 2019-03-31 | $5.65M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $6.83M 10-K · filed 2020-03-24 |
| 2018-09-30 | $6.42M 10-Q · filed 2018-11-13 |
| 2018-06-30 | $7.33M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $8.22M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $9.11M 10-K · filed 2019-03-21 |